Geodesic launches NovaDDE platform targeting AGI for drug discovery
QuanquanGu · x · 2026-09-10
- Geodesic, founded by UCLA professor Quanquan Gu's team, is launching an AI-native platform for protein therapeutics, positioning itself as "building AGI for drug discovery" to find the shortest path from biology to medicines.
- First releases include NovaDDE and NovaAtom-Lite-Preview; early-access users praise its protein design capabilities for drug discovery and synthetic biology.
Related event: UCLA's Quanquan Gu founds Geodesic to build AGI for drug discovery(4 posts)→
More from Apps
- iPhone Duo called the first agentic cyberdeck — and the timing is finally right — michalmalewicz · 2026-09-10
- Open-source skill turns AI into interactive multi-page 'Explorable Explanations' with JS games — danshipper · 2026-09-10
- iPhone Duo support absent from Xcode, devs expect it with iOS 27.1 — talkaboutdesign · 2026-09-10
- Shopify CEO's neohack game now generates an AI short story and replay after you die — BLUECOW009 · 2026-09-10
- Internal medicine physician says AI health service can help patients he couldn't — relic_radiation · 2026-09-10
- Zuckerberg details Muse agent's confidential VM that even Meta can't see into — soleio · 2026-09-10